P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Main Authors: | Turner SJ, Doherty PC, Hurt A, Laurie K, Moffat JM, Loh L, Alcantara S, Reece JC, De Rose R, Sexton A, Stambas J, Kent SJ |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Retrovirology |
Similar Items
-
Comparison of influenza and SIV specific CD8 T cell responses in macaques.
by: Sinthujan Jegaskanda, et al.
Published: (2012-01-01) -
A recombinant attenuated Mycobacterium tuberculosis-SIV combination vaccine is safe and immunogenic in immunocompromised, SIV-infected infant macaques
by: Jensen K, et al.
Published: (2012-09-01) -
Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood.
by: Robert De Rose, et al.
Published: (2008-05-01) -
Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy
by: B. Ling, et al.
Published: (2017-12-01) -
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
by: Zhang X, et al.
Published: (2012-09-01)